Fig. 2: Patient outcomes.
Progression-free survival (A) and overall survival (B) in MM patients who underwent auto-HCT with either ≤2.5 × 106 CD34+ cells/kg or >2.5 × 106 CD34+ cells/kg.
Fig. 2: Patient outcomes. | Blood Cancer Journal
Progression-free survival (A) and overall survival (B) in MM patients who underwent auto-HCT with either ≤2.5 × 106 CD34+ cells/kg or >2.5 × 106 CD34+ cells/kg.
